Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage
Open Access
- 29 November 2007
- journal article
- research article
- Published by Springer Nature in Genetic Vaccines and Therapy
- Vol. 5 (1), 12
- https://doi.org/10.1186/1479-0556-5-12
Abstract
Background: Vaccination of neonates is generally difficult due to the immaturity of the immune system and consequent higher susceptibility to tolerance induction. Genetic immunization has been described as an alternative to trigger a stronger immune response in neonates, including significant Th1 polarization. In this investigation we analysed the potential use of a genetic vaccine containing the heat shock protein (hsp65) fromMycobacterium leprae(pVAXhsp65) against tuberculosis (TB) in neonate mice. Aspects as antigen production, genomic integration and immunogenicity were evaluated.Methods: Hsp65 message and genomic integration were evaluated by RT-PCR and Southern blot, respectively. Immunogenicity of pVAXhsp65 alone or combined with BCG was analysed by specific induction of antibodies and cytokines, both quantified by ELISA.Results: This DNA vaccine was transcribed by muscular cells of neonate mice without integration into the cellular genome. Even though this vaccine was not strongly immunogenic when entirely administered (three doses) during early animal's life, it was not tolerogenic. In addition, pVAXhsp65 and BCG were equally able to prime newborn mice for a strong and mixed immune response (Th1 + Th2) to pVAXhsp65 boosters administered later, at the adult life.Conclusion: These results suggest that pVAXhsp65 can be safely used as a priming stimulus in neonate animals in prime-boost similar strategies to control TB. However, priming with BCG or pVAXhsp65, directed the ensuing immune response triggered by an heterologous or homologous booster, to a mixed Th1/Th2 pattern of response. Measures as introduction of IL-12 or GM-CSF genes in the vaccine construct or even IL-4 neutralization, are probably required to increase the priming towards Th1 polarization to ensure control of tuberculosis infection.Keywords
This publication has 50 references indexed in Scilit:
- Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progressionClinical and Experimental Immunology, 2007
- Role of bacillus Calmette–Guérin as an immunomodulator for the prevention and treatment of allergy and asthmaCurrent Opinion in Allergy and Clinical Immunology, 2005
- Immunomodulation and Protection Induced by DNA-hsp65 Vaccination in an Animal Model of ArthritisHuman Gene Therapy, 2005
- CD4+CD25+FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen‐specific T cell responsesImmunology, 2005
- DNA vaccines coding for heat-shock proteins (HSPs): tools for the activation of HSP-specific regulatory T cellsExpert Opinion on Biological Therapy, 2005
- CD4+CD25high regulatory T cells in human pregnancyJournal of Reproductive Immunology, 2005
- Biodistribution and general safety of a naked DNA plasmid, GTU®-MultiHIV, in a rat, using a quantitative PCR methodVaccine, 2005
- Neonatal adaptive immunity comes of ageNature Reviews Immunology, 2004
- Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2‐biased pattern which persists after adult boostingEuropean Journal of Immunology, 1996
- Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.The Journal of Experimental Medicine, 1990